cbdMD
YCBD
19 hedge funds and large institutions have $101K invested in cbdMD in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 7 closing their positions.
0.48% less ownership
Funds ownership: 0.92% → 0.45% (-0.48%)
21% less funds holding
Funds holding: 24 → 19 (-5)
55% less capital invested
Capital invested by funds: $227K → $101K (-$125K)
71% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 7
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$11.2K |
| 2 |
Renaissance Technologies
New York
|
+$3.61K |
| 3 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$234 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
AXS Investments
Port Chester,
New York
|
-$94.9K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$17.9K |
| 3 |
PCM
Penserra Capital Management
Orinda,
California
|
-$12K |
| 4 |
Fifth Third Bancorp
Cincinnati,
Ohio
|
-$4.03K |
| 5 |
VF
Virtu Financial
New York
|
-$2.63K |
YCBD Hedge Fund Activity: Q1 2024 in Review
19 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in cbdMD (YCBD) for Q1 2024, worth a combined $101K — down 55% from $227K a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of YCBD and 2 opened new positions — a net loss of 5 holders — while 4 trimmed existing stakes and 1 added.
The largest buyer was UBS Group, opening a new position worth an estimated $11.2K. The largest seller was AXS Investments, exiting entirely with an estimated $94.9K sold.
- 19 institutional investors held cbdMD (YCBD) as of Q1 2024, down from 24 in Q4 2023.
- Funds reported $101K of cbdMD stock for Q1 2024, down 55% quarter-over-quarter.
- 2 funds opened new cbdMD positions in Q1 2024 and 7 closed out, a net change of -5 holders.
- The largest cbdMD buyer in Q1 2024 was UBS Group, an estimated $11.2K added.
- The largest cbdMD seller in Q1 2024 was AXS Investments, an estimated $94.9K sold.
Based on aggregated 13F filings for Q1 2024.